<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02787213</url>
  </required_header>
  <id_info>
    <org_study_id>SP 014</org_study_id>
    <nct_id>NCT02787213</nct_id>
  </id_info>
  <brief_title>A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor</brief_title>
  <acronym>TREETOP</acronym>
  <official_title>A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sera Prognostics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sera Prognostics, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective multicenter observational study to further develop and validate a preterm birth
      risk predictor, using a preterm cutoff at 37 0/7 weeks gestation and at 35 0/7 weeks
      gestation. A single maternal peripheral blood sample will be collected for analysis. Data
      related to potential risk factors for preterm birth will be obtained through maternal
      interview and review of medical records. Subjects will be followed through the delivery
      process to assess the course of pregnancy, labor, and to document any related maternal
      complications. Neonatal outcomes will be gathered from the medical record for up to 28 days
      of life or discharge, whichever occurs first.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the receiver operator characteristic curve (AUROC) for prediction of preterm versus term birth using freshly collected specimens.</measure>
    <time_frame>Up to 30 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>Women with preterm delivery</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Women without preterm delivery</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women, 18 years or older, who are receiving prenatal care.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is 18 years of age or older

          -  Subject has singleton gestation

          -  Subject is able to provide consent

          -  Gestational age is confirmed by a documented crown rump length on an ultrasound
             performed at the study site within 6 0/7 weeks and 13 6/7 weeks gestation (first
             trimester)

          -  Subject has no signs and/or symptoms of preterm labor and has intact membranes

          -  Investigator believes subject is willing to comply with study visits and procedures

          -  Investigator believes the subject's delivery data will be available within 15 business
             days from delivery, and neonatal data will be available for data collection purposes
             within 15 business days

        Exclusion Criteria:

          -  The subject has a planned cesarean section or induction of labor prior to 370/7 weeks
             of gestation

          -  The subject has a planned cerclage placement for the current pregnancy

          -  There is a known or suspected fetal anomaly or chromosomal abnormality

          -  The subject has had a blood transfusion during the current pregnancy

          -  The subject has known elevated bilirubin levels (hyperbilirubinemia)

          -  The subject has taken or plans to take any of the following medications during the
             current pregnancy:

               -  Progesterone or progesterone-derivative medication after 13 6/7 weeks gestation

               -  Enoxaparin, heparin, heparin sodium, low molecular weight heparin after first day
                  of last menstrual period

          -  The subject has participated in, or plans to participate in, an interventional
             treatment study during the current pregnancy

          -  The current pregnancy was previously a multiple gestation that is now a single fetus
             due to reduction, vanishing twin, etc.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Durlin E Hickok, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sera Prognostics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Durlin E Hickok, MD</last_name>
    <phone>206-660-0301</phone>
    <email>dhickok@seraprognostics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angela Fox, MS</last_name>
    <phone>206-465-0905</phone>
    <email>afox@seraprognostics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maricopa Integrated Health Systems</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85250</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dean Coonrod, MD</last_name>
      <phone>602-344-5119</phone>
      <email>dean_coonrod@dmgaz.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California, Irvine Medical Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Wing, MD</last_name>
      <phone>714-456-5967</phone>
      <email>dwing@uci.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UC San Diego Health</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise Laurent, MD/PhD</last_name>
      <phone>858-246-1405</phone>
      <email>llaurent@ucsd.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Denver Health Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kent Heyborne, MD</last_name>
      <phone>303-602-9731</phone>
      <email>kent.heyborne@dhha.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale-New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Grobman, MD</last_name>
      <phone>312-472-3970</phone>
      <email>w-grobman@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana University Medical Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Haas, MD</last_name>
      <phone>317-880-3960</phone>
      <email>dahaas@iu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Baptist Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry Longo, MD</last_name>
      <phone>504-842-4151</phone>
      <email>slongo@ochsner.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Glenn Markenson, MD</last_name>
      <phone>617-414-2275</phone>
      <email>glenn.markenson@bmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corina Schoen, MD</last_name>
      <phone>413-794-9939</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Murtha, MD</last_name>
      <phone>919-684-6327</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Science Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Baxter, MD</last_name>
      <phone>215-955-9238</phone>
      <email>jason.baxter@jefferson.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29485</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Sullivan, MD</last_name>
      <phone>843-792-4500</phone>
      <email>sullivas@musc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regional Obstetrical Consultants</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Saade, MD</last_name>
      <phone>409-747-0476</phone>
      <email>gsaade@utmb.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Saade GR, Boggess KA, Sullivan SA, Markenson GR, Iams JD, Coonrod DV, Pereira LM, Esplin MS, Cousins LM, Lam GK, Hoffman MK, Severinsen RD, Pugmire T, Flick JS, Fox AC, Lueth AJ, Rust SR, Mazzola E, Hsu C, Dufford MT, Bradford CL, Ichetovkin IE, Fleischer TC, Polpitiya AD, Critchfield GC, Kearney PE, Boniface JJ, Hickok DE. Development and validation of a spontaneous preterm delivery predictor in asymptomatic women. Am J Obstet Gynecol. 2016 May;214(5):633.e1-633.e24. doi: 10.1016/j.ajog.2016.02.001. Epub 2016 Feb 11.</citation>
    <PMID>26874297</PMID>
  </reference>
  <reference>
    <citation>Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012 Jun 9;379(9832):2162-72. doi: 10.1016/S0140-6736(12)60820-4.</citation>
    <PMID>22682464</PMID>
  </reference>
  <reference>
    <citation>Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. 1998 Jul 30;339(5):313-20. Review.</citation>
    <PMID>9682045</PMID>
  </reference>
  <reference>
    <citation>Rush RW, Keirse MJ, Howat P, Baum JD, Anderson AB, Turnbull AC. Contribution of preterm delivery to perinatal mortality. Br Med J. 1976 Oct 23;2(6042):965-8.</citation>
    <PMID>974709</PMID>
  </reference>
  <reference>
    <citation>Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012 Jun 9;379(9832):2151-61. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11. Erratum in: Lancet. 2012 Oct 13;380(9850):1308.</citation>
    <PMID>22579125</PMID>
  </reference>
  <reference>
    <citation>Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, McCormack A, Lapidus JA, Hitti J, Eschenbach DA, Roberts CT Jr, Nagalla SR. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004 Jul 28;292(4):462-9. Erratum in: JAMA. 2004 Nov;292(19):2340.</citation>
    <PMID>15280344</PMID>
  </reference>
  <reference>
    <citation>Rüetschi U, Rosén A, Karlsson G, Zetterberg H, Rymo L, Hagberg H, Jacobsson B. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res. 2005 Nov-Dec;4(6):2236-42.</citation>
    <PMID>16335971</PMID>
  </reference>
  <reference>
    <citation>Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, Sfakianaki AK, Pettker CM, Magloire L, Funai E, Norwitz ER, Paidas M, Copel JA, Weiner CP, Lockwood CJ, Buhimschi IA. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med. 2007 Jan;4(1):e18.</citation>
    <PMID>17227133</PMID>
  </reference>
  <reference>
    <citation>Gravett MG, Thomas A, Schneider KA, Reddy AP, Dasari S, Jacob T, Lu X, Rodland M, Pereira L, Sadowsky DW, Roberts CT Jr, Novy MJ, Nagalla SR. Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res. 2007 Jan;6(1):89-96.</citation>
    <PMID>17203952</PMID>
  </reference>
  <reference>
    <citation>Pereira L, Reddy AP, Jacob T, Thomas A, Schneider KA, Dasari S, Lapidus JA, Lu X, Rodland M, Roberts CT Jr, Gravett MG, Nagalla SR. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res. 2007 Apr;6(4):1269-76. Epub 2007 Mar 21.</citation>
    <PMID>17373840</PMID>
  </reference>
  <reference>
    <citation>Esplin MS, Merrell K, Goldenberg R, Lai Y, Iams JD, Mercer B, Spong CY, Miodovnik M, Simhan HN, van Dorsten P, Dombrowski M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2011 May;204(5):391.e1-8. doi: 10.1016/j.ajog.2010.09.021. Epub 2010 Nov 11.</citation>
    <PMID>21074133</PMID>
  </reference>
  <reference>
    <citation>Committee opinion no 611: method for estimating due date. Obstet Gynecol. 2014 Oct;124(4):863-6. doi: 10.1097/01.AOG.0000454932.15177.be. Review.</citation>
    <PMID>25244460</PMID>
  </reference>
  <reference>
    <citation>Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983 Sep;148(3):839-43.</citation>
    <PMID>6878708</PMID>
  </reference>
  <reference>
    <citation>Obuchowski NA, McClish DK. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Stat Med. 1997 Jul 15;16(13):1529-42.</citation>
    <PMID>9249923</PMID>
  </reference>
  <reference>
    <citation>Buhimschi IA, Christner R, Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG. 2005 Feb;112(2):173-81.</citation>
    <PMID>15663581</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2016</study_first_submitted>
  <study_first_submitted_qc>May 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2016</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>proteomics</keyword>
  <keyword>pregnancy</keyword>
  <keyword>biomarkers</keyword>
  <keyword>preterm birth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be shared once it is published.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

